VIRGINIA RETIREMENT SYSTEMS ET AlVIRGINIA RETIREMENT SYSTEMS ET Al

Institutional investor · Portfolio as of Q2 2023

SEC EDGAR SourceSEC Filings

Top Holdings963 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

APPLE INC

3.4M$666.6M6.4%$97.48+91.97%
23 qtrssince 2017-Q3
Increased
62

MICROSOFT CORP

1.5M$494M4.7%$109.61+199.93%
23 qtrssince 2017-Q3
Increased
57

BROADCOM INC

215,891$187.3M1.8%$49.64+68.24%
20 qtrssince 2018-Q2
Unchanged
0

AMAZON.COM INC

1.4M$178.1M1.7%$114.35+11.85%
23 qtrssince 2017-Q3
Increased
54

NVIDIA CORP

392,779$166.2M1.6%$19.54+108.75%
23 qtrssince 2017-Q3
Increased
51

ALPHABET INC-CL A

1.3M$153.9M1.5%$97.04+21.82%
23 qtrssince 2017-Q3
Increased
53

MERCK & CO. INC.

1.3M$151.6M1.5%$64.96+61.71%
23 qtrssince 2017-Q3
Increased
49

META PLATFORMS INC-CLASS A

486,096$139.5M1.3%$182.14+53.49%
23 qtrssince 2017-Q3
Increased
50

EXXON MOBIL CORP

1.3M$134.9M1.3%$65.40+48.59%
23 qtrssince 2017-Q3
Unchanged
0

CISCO SYSTEMS INC

2.5M$131.4M1.3%$43.70+8.46%
23 qtrssince 2017-Q3
Increased
48

ACCENTURE PLC-CL A

397,228$122.6M1.2%$154.66+91.95%
23 qtrssince 2017-Q3
Unchanged
0

BERKSHIRE HATHAWAY INC-CL B

352,100$120.1M1.2%$198.93+69.36%
23 qtrssince 2017-Q3
Unchanged
0

ALPHABET INC-CL C

908,100$109.9M1.1%$94.92+25.50%
23 qtrssince 2017-Q3
Decreased
0

VERTEX PHARMACEUTICALS INC

297,900$104.8M1.0%$221.27+57.36%
16 qtrssince 2019-Q2
Increased
48

KLA CORP

213,692$103.6M1.0%$305.52+52.68%
23 qtrssince 2017-Q3
Increased
42

GILEAD SCIENCES INC

1.3M$97.3M0.9%$64.88+7.46%
4 qtrssince 2022-Q3
Increased
43

LOCKHEED MARTIN CORP

202,802$93.4M0.9%$355.15+20.26%
23 qtrssince 2017-Q3
Unchanged
0
PLDPLD
REIT

PROLOGIS INC

745,286$91.4M0.9%$75.50+48.49%
23 qtrssince 2017-Q3
Unchanged
0

VISA INC-CLASS A SHARES

381,121$90.5M0.9%$170.78+34.39%
23 qtrssince 2017-Q3
Unchanged
0

TESLA INC

338,431$88.6M0.8%$247.97+3.84%
12 qtrssince 2020-Q2
Increased
47
$10.4B
AUM
963
Positions
Q2 2023
Filing
Rating · 1.5
Quarterly Portfolio Change
+50%Q4'21$14.7B-27%Q1'22$10.7B-17%Q3'22$8.8B+9%Q4'22$9.6B+1%Q1'23$9.7B+8%Q2'23$10.4B
Activity profile
$ moved · Q2'23
New8%Increased52%Decreased25%Exited15%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.9 years
<1Q3%1-4Q13%1-2Y6%2Y+77%

VIRGINIA RETIREMENT SYSTEMS ET Al manages $10.4B across 963 positions as of Q2 2023. Top holdings: AAPL (6.4%), MSFT (4.7%), AVGO (1.8%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 1.5/5.0.

Q2 2023 Summary

Active quarter - 114 new positions, 178 exits, 410 increased. Top move: AAPL (INCREASED, conviction 62). Portfolio: $10.4B across 963 positions.

Top holdings by portfolio weight

Total AUM$10B
AAPL6.39%
MSFT4.74%
AVGO1.80%
AMZN1.71%
NVDA1.59%
GOOGL1.48%
MRK1.45%
META1.34%
XOM1.29%
CSCO1.26%
Other1.18%

Portfolio allocation by GICS sector

Sectors11
Technology26.20%
Healthcare14.53%
Financial Services11.13%
Industrials10.05%
Consumer Cyclical10.03%
Real Estate7.00%
Consumer Defensive6.51%
Communication Services5.93%
Energy2.94%
Utilities2.20%
Other3.48%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Technology, Healthcare, Financial Services
Compare DNA across all funds
7-dimension quality assessment

Last filed Q4 2025 - no longer filing.

Below Average(1.5 / 5.0)
Track RecordNo data
Conviction41
Concentration0
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
4Q
PECOPECOPHILLIPS EDISON & COMPANY IN
Q1 2025 Q4 2025+37,738 shares+$1.4M
4Q
WELLWELLWELLTOWER INC
Q1 2025 Q4 2025+261,400 shares+$61.8M
4Q
BCRXBCRXBIOCRYST PHARMACEUTICALS INC
Q1 2025 Q4 2025+186,254 shares+$1.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used